A medication that can extend the life expectancy of Australians living with a debilitating disease will see a price drop of $250,000 a year.
Check Also
Gemma Acton: Qantas continues to let Aussies down despite soaring profits
From pilots to planes, Qantas failed to ensure they were kept anywhere near match-fit for …